Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
30,228,946
-
Share change
-
+4,331,858
-
Total reported value
-
$1,725,187,126
-
Put/Call ratio
-
44%
-
Price per share
-
$57.07
-
Number of holders
-
100
-
Value change
-
+$251,722,518
-
Number of buys
-
63
-
Number of sells
-
36
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q4 2022
As of 31 Dec 2022,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,228,946 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Avidity Partners Management LP, GENERAL ATLANTIC, L.P., Paradigm Biocapital Advisors LP, and BlackRock Inc..
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.